Skip to main content

Pay Bill Portals

Our Tests
Our Services
- - Oncology
    - - SERVICES
        
        NateraCore Services
        
        Pharma Partnership
    - - FOR PATIENTS
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
        
        Contact Us
    - - FOR CLINICIANS
        
        Schedule Session With Client Services
        
        Oncology Portal
        
        Order a Test Kit
        
        Contact Us
  - Organ Health
    - - SERVICES
        
        NateraCore Services
        
        ProReach
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Contact Us
    - - FOR CLINCIANS
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - SERVICES
        
        NateraCore Services
        
        Constellation
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
        
        Women’s Health Portal
        
        Contact Us
    - - FOR CLINICIANS
        
        Order Tests and Track Status on NateraConnect
        
        View Patient Results on NateraConnect
        
        Contact Us
Patient Resources
- - Oncology
    - - LEARN
        
        Signatera
        Altera
        Empower
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Organ Health
    - - LEARN
        
        Prospera
        Renasight
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule a Genetic Information Session
    - - CONNECT
        
        Contact Us
  - Women’s Health
    - - LEARN
        
        Horizon
        Panorama
        Empower
        Vistara
        Anora
        Spectrum
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients)
        
        Pricing and Billing Information
        
        Women’s Health Portal
    - - CONNECT
        
        Contact Us
Clinical Resources
- - Oncology
    - - CLINICAL RESOURCES
        
        Order Forms
        
        Signatera
        Signatera Publications
        Altera
        Empower
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        Signatera Research Pipeline
        
        BESPOKE CRC
        
        BESPOKE IO
    - - CONNECT
        
        Oncology Portal
        
        Contact Us
  - Organ Health
    - - CLINICAL RESOURCES
        
        Organ Health Publications
        Prospera
        Renasight
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        ProActive Study
        
        PEDAL Study
        
        Trifecta Study
        
        MOTR Study
    - - CONNECT
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - CLINICAL RESOURCES
        
        Women’s Health Publications
        Horizon
        Panorama
        Empower
        Vistara
        Anora
        Spectrum
        Natera Academy Provider Education Hub
        View All Clinician Resources
    - - RESEARCH STUDIES
    - - CONNECT
        
        Contact Us
Company
Search for:
Pay Bill

Portals
Search for:

Natera, Inc.

- Altera
- Anora
- Empower
- Horizon
- Panorama
- Prospera
- Renasight
- Signatera
- Spectrum
- Vistara
- Blog
- Videos
- Brochure
- Whitepaper
- Manual
- Poster
- Report
- Study
- Webinars
- Natera Academy

Recent Searches

Home
Wistia - Signatera: All
Latest data on ctDNA as a patient selection and early efficacy marker for gynecologic cancers

Latest data on ctDNA as a patient selection and early efficacy marker for gynecologic cancers

Published Date May 31, 2024

Previous Video

ASCO24 Summary: Latest data on ctDNA as a patient selection and early efficacy marker in drug development
Next Video

Natera Analogy of Radon Testing to Signatera testing - social - d1 - with captions

Most Recent Videos

about 1 month ago
4379_Natera_Danielle_V4A - Captioned

Watch Video
3 months ago
ASCO24 Summary: Latest data on ctDNA as a patient selection and early efficacy marker in drug development

Watch Video
4 months ago
Natera Analogy of Radon Testing to Signatera testing - social - d1 - with captions

Watch Video
4 months ago
Natera Signatera gave me more time - social - d1 - with captions

Watch Video
5 months ago
Brent's Story

Watch Video
6 months ago
Using ctDNA to help inform the management of patients with low-risk colorectal cancer (with subtitles)

Watch Video
6 months ago
Using ctDNA to help inform the management of patients with low-risk colorectal cancer

Watch Video
6 months ago
Using ctDNA to help inform the management of patients with locally advanced rectal cancer (with subtitles)

Watch Video
6 months ago
Using ctDNA to help inform the management of patients with locally advanced rectal cancer

Watch Video
6 months ago
The expanding role of ctDNA in colorectal cancer to optimize patient management

Watch Video
6 months ago
The expanding role of ctDNA in colorectal cancer to optimize patient management (with subtitles)

Watch Video
7 months ago
How ctDNA can transform interventional trial design for GI cancers

Watch Video
8 months ago
Seeing the Forest Through the Trees: How tumor informed MRD testing can illuminate the treatment pathway in GI cancer

Review recently presented MRD data in colorectal and pancreatic cancer, exploring the potential impact on patient care

Watch Video
9 months ago
Seeing the Forest Through the Trees: Using tumor-informed MRD testing to illuminate the treatment pathway in GI cancer

Watch Video
10 months ago
Personalized ctDNA testing to help guide treatment decisions in breast cancer

Watch Video
10 months ago
Webinar: Breast Cancer 2023 Data & Post-SABCS Summary

ctDNA in drug development for breast cancer Multiple studies have demonstrated that detection of molecular residual disease (MRD) is associated with poor prognosis in breast cancer. Ongoing prospectiv

Watch Video
11 months ago
Panel Discussion: How ctDNA Testing is Informing the Management of Patients With GI Cancer - Direct

Our experts will review real-world case studies showing when and where ctDNA can help inform shared decision-making.

Watch Video
11 months ago
Locate and Track: ctDNA Monitoring in NSCLC with Signatera

Learn about the clinical applications for Signatera in NSCLC across early stage and metastatic disease

Watch Video
12 months ago
Keith's Story

Listen in how one CRC patient and his physician used Signatera as a part of his treatment strategy to help identify an early signal that cancer may be lurking.

Watch Video
about 1 year ago
ctDNA monitoring to optimize immunotherapy treatment decisions

Dive into the latest data highlighting ctDNA for immunotherapy treatment response monitoring

Watch Video

Return to Resource Library

© Natera, Inc.

Our Tests
Our Services
Patient Resources
Clinical Resources
- Resource Library
- Provider Portals
Company
Contact

Natera Licenses
IT Security Compliance
Natera Notice of Data Collection for California Residents
Privacy Practices
Privacy Policy
Terms of Use
Sitemap

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2024 Natera, Inc. All Rights Reserved.